ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637459; 2) Community: the network communities that were significantly associated with the response to NSC 637459; 3) Molecule: the relationships between components within communities and NSC 637459; 4) MDR: the compounds that were significantly associated with the NSC 637459.

NSC Compound Enrichment Correlation
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0114553853234976 0.34860704
NSC 100880 Camptothecin 0.0114553853234977 0.085291584
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0114553853234977 0.13814228
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0114553853234977 0.46485774
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0114553853234977 0.520522
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0114553853234977 0.06073532
NSC 303861 L-Cysteine analog 0.0114553853234977 0.59059268
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0114553853234977 0.26733464
NSC 359239 Antibiotic X-14766A 0.0114553853234977 -0.07122043
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0114553853234977 0.22317929
Total:84  Current:26    [First] [Prev] [Next] [Last]